4//SEC Filing
Bradway Robert A 4
Accession 0001127602-24-014847
CIK 0000318154other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 6:58 PM ET
Size
8.0 KB
Accession
0001127602-24-014847
Insider Transaction Report
Form 4
AMGEN INCAMGN
Bradway Robert A
Executive V.P. and CFO
Transactions
- Award
Common Stock
2024-05-07+11,988→ 669,269 total - Award
Nqso (Right to Buy)
2024-05-07$300.30/sh+77,877$23,386,463→ 77,877 totalExercise: $300.30From: 2026-05-07Exp: 2034-05-07→ Common Stock (77,877 underlying)
Footnotes (3)
- [F1]These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 4,516 RSUs which will vest on 4/30/2025; 9,234 RSUs which will vest in installments of 4,548 on 5/2/2025, and 4,686 on 5/2/2026; 13,486 RSUs which will vest in two installments of 4,450 each on 5/2/2025 and 5/2/2026, and one installment of 4,586 on 5/2/2027; and 11,988 RSUs which will vest in two installments of 3,956 on 5/7/2026 and on 5/7/2027, and one installment of 4,076 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F2]These shares include 1,555 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
- [F3]These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeother
Related Parties
1- filerCIK 0001396482
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 6:58 PM ET
- Size
- 8.0 KB